Active ingredient
Anagrelide
7 finished FDA listings contain Anagrelide as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- ANAGRELIDE HYDROCHLORIDE, ANAGRELIDE HYDROCHLORIDE ANHYDROUS
- Dosage forms
- Capsule
- Routes
- Oral
- Manufacturers / labelers
- 4
- Strengths listed
- .5 mg/1 · 1 mg/1
- Brand names in FDA listings
- Agrylin
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 596724
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 020333 | TAKEDA PHARMS USA | 1997-03-14 | 1 |
| ANDA 076683 | CHARTWELL RX | 2005-04-18 | 2 |
| ANDA 076811 | NOVITIUM PHARMA | 2005-04-18 | 2 |
| ANDA 209151 | TORRENT | 2017-06-30 | 2 |
Official labeling on DailyMed
- ANAGRELIDE CAPSULE [TORRENT PHARMACEUTICALS LIMITED] · version 11 · 2026-08-19
- ANAGRELIDE CAPSULE [ANI PHARMACEUTICALS, INC.] · version 2 · 2026-07-13
- AGRYLIN (ANAGRELIDE HYDROCHLORIDE) CAPSULE [TAKEDA PHARMACEUTICALS AMERICA, INC.] · version 43 · 2026-04-10
- ANAGRELIDE CAPSULE [CHARTWELL RX, LLC] · version 1 · 2024-03-08
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.